275 related articles for article (PubMed ID: 27487479)
1. Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.
Schrantee A; Tamminga HG; Bouziane C; Bottelier MA; Bron EE; Mutsaerts HJ; Zwinderman AH; Groote IR; Rombouts SA; Lindauer RJ; Klein S; Niessen WJ; Opmeer BC; Boer F; Lucassen PJ; Andersen SL; Geurts HM; Reneman L
JAMA Psychiatry; 2016 Sep; 73(9):955-62. PubMed ID: 27487479
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate Effects on Cortical Thickness in Children and Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.
Walhovd KB; Amlien I; Schrantee A; Rohani DA; Groote I; Bjørnerud A; Fjell AM; Reneman L
AJNR Am J Neuroradiol; 2020 May; 41(5):758-765. PubMed ID: 32414901
[TBL] [Abstract][Full Text] [Related]
3. White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder.
Bouziane C; Filatova OG; Schrantee A; Caan MWA; Vos FM; Reneman L
Radiology; 2019 Oct; 293(1):186-192. PubMed ID: 31407970
[TBL] [Abstract][Full Text] [Related]
4. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
[TBL] [Abstract][Full Text] [Related]
5. Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.
Philipsen A; Jans T; Graf E; Matthies S; Borel P; Colla M; Gentschow L; Langner D; Jacob C; Groß-Lesch S; Sobanski E; Alm B; Schumacher-Stien M; Roesler M; Retz W; Retz-Junginger P; Kis B; Abdel-Hamid M; Heinrich V; Huss M; Kornmann C; Bürger A; Perlov E; Ihorst G; Schlander M; Berger M; Tebartz van Elst L;
JAMA Psychiatry; 2015 Dec; 72(12):1199-210. PubMed ID: 26536057
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder.
Schrantee A; Bouziane C; Bron EE; Klein S; Bottelier MA; Kooij JJS; Rombouts SARB; Reneman L
Brain Imaging Behav; 2018 Apr; 12(2):402-410. PubMed ID: 28321605
[TBL] [Abstract][Full Text] [Related]
7. The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder.
Schrantee A; Mutsaerts H; Bouziane C; Tamminga H; Bottelier MA; Reneman L
Neuroimage Clin; 2017; 13():123-129. PubMed ID: 27942455
[TBL] [Abstract][Full Text] [Related]
8. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
[TBL] [Abstract][Full Text] [Related]
9. A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment.
del Campo N; Fryer TD; Hong YT; Smith R; Brichard L; Acosta-Cabronero J; Chamberlain SR; Tait R; Izquierdo D; Regenthal R; Dowson J; Suckling J; Baron JC; Aigbirhio FI; Robbins TW; Sahakian BJ; Müller U
Brain; 2013 Nov; 136(Pt 11):3252-70. PubMed ID: 24163364
[TBL] [Abstract][Full Text] [Related]
10. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
[TBL] [Abstract][Full Text] [Related]
11. Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination.
Smith A; Cubillo A; Barrett N; Giampietro V; Simmons A; Brammer M; Rubia K
Biol Psychiatry; 2013 Oct; 74(8):615-22. PubMed ID: 23731741
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder.
Rosa-Neto P; Lou HC; Cumming P; Pryds O; Karrebaek H; Lunding J; Gjedde A
Neuroimage; 2005 Apr; 25(3):868-76. PubMed ID: 15808987
[TBL] [Abstract][Full Text] [Related]
13. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
[TBL] [Abstract][Full Text] [Related]
14. Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.
Jafarinia M; Mohammadi MR; Modabbernia A; Ashrafi M; Khajavi D; Tabrizi M; Yadegari N; Akhondzadeh S
Hum Psychopharmacol; 2012 Jul; 27(4):411-8. PubMed ID: 22806822
[TBL] [Abstract][Full Text] [Related]
15. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J
Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
17. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
Levin FR; Mariani JJ; Specker S; Mooney M; Mahony A; Brooks DJ; Babb D; Bai Y; Eberly LE; Nunes EV; Grabowski J
JAMA Psychiatry; 2015 Jun; 72(6):593-602. PubMed ID: 25887096
[TBL] [Abstract][Full Text] [Related]
18. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
Wilens TE
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
[TBL] [Abstract][Full Text] [Related]
19. MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder.
Schweren LJ; de Zeeuw P; Durston S
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1151-64. PubMed ID: 23165220
[TBL] [Abstract][Full Text] [Related]
20. Effects of a single-dose methylphenidate challenge on resting-state functional connectivity in stimulant-treatment naive children and adults with ADHD.
Kaiser A; Broeder C; Cohen JR; Douw L; Reneman L; Schrantee A
Hum Brain Mapp; 2022 Oct; 43(15):4664-4675. PubMed ID: 35781371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
